Latest CSBR reports update at 2023-12-13: 2023-Q32023-Q12022-Q3
Champions Oncology logo
Champions Oncology CSBR
$ 5.13 5.36%

Champions Oncology Financial Ratios 2011-2024 | CSBR

Annual Financial Ratios Champions Oncology

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-16.9 210.5 290.4 -60.0 845.2 -32.5 -3.9 -2.8 -4.4 -8.6 -2.5 -3.4 -9.1

P/S

1.7 2.3 2.6 3.7 4.0 2.4 1.7 2.6 6.5 5.5 1.9 4.1 5.0

EPS

-0.4 0.0 0.0 -0.2 0.0 -0.1 -0.6 -1.2 -2.2 -0.1 -0.1 -0.2 -0.1

EV (Enterprise Value)

110 M 133 M 121 M 126 M 114 M 55.2 M 31.2 M 31.8 M 52.1 M 63.3 M 10.1 M 36.5 M 36.8 M

EBITDA per Share

-0.23 0.16 0.1 -0.09 0.0772 -0.0903 -0.605 -1.17 -1.5 -1.08 -2.03 -2.3 -1.71

EV/EBITDA

77.0 -164.4 119.8 -47.4 -3.6 -2.6 -3.7 -9.5 -1.0 -2.7 -4.7

PEG

0.11 -1.65 -1.95 0.54 7.81 -0.42 -0.08 -0.13 0.32 -0.22 -0.51 0.04 0.82

P/B

19.5 12.7 14.2 22.3 48.3 15991.4 67.3 121.1 7.1 19.9 2.0 -5.5 1822.0

P/CF

22.7 17.8 -62.5 40.8 105.2 -19.5 -7.5 -4.3 -5.9 -17.3 -3.6 -5.1 -249.1

ROE %

-115.08 6.02 4.87 -38.73 5.72 -49200.00 -1721.00 -4389.08 -163.05 -231.65 -82.46 164.10 -20010.53

ROA %

-15.55 1.55 1.31 -9.52 1.14 -18.27 -85.93 -180.82 -109.07 -83.52 -54.33 -125.12 -30.06

ROCE %

-113.37 6.67 4.93 -37.67 8.33 -216.64 -1207.27 -2190.23 -160.44 -120.20 -71.33 -263.82 -57.21

Current Ratio

1.2 1.3 1.4 1.3 1.0 0.7 0.8 0.8 2.8 2.1 3.5 1.6 3.4

DSO

59.4 61.3 52.3 52.0 59.0 70.6 53.9 42.8 43.7 41.9 21.9 29.8 58.4

DIO

- - - - - - - - - - - - -

DPO

50.7 36.8 42.8 63.8 71.8 74.5 69.7 79.7 67.6 57.2 82.5 124.9 183.5

Operating Cycle

59.4 61.3 52.3 52.0 59.0 70.6 53.9 42.8 43.7 41.9 21.9 29.8 58.4

Cash Conversion Cycle

8.7 24.5 9.4 -11.9 -12.8 -3.9 -15.8 -36.8 -24.0 -15.3 -60.6 -95.1 -125.1

All numbers in USD currency

Quarterly Financial Ratios Champions Oncology

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.15 -0.19 - 0.06 - -0.02 - 0.07 0.02 0.01 - 0.03 - - 0.01 -0.03 0.03 0.03 -0.06 -0.01 0.02 0.02 0.04 -0.13 -0.01 -0.06 - -0.28 -0.05 -0.05 -0.26 -0.51 -0.29 -0.63 - -0.01 -0.55 -0.05 - -0.02 -0.03 -0.07 -0.03 -0.04 -0.04 -0.04 -0.03 -0.01 -0.05 -0.05 -0.04

EBITDA per Share

-0.11 -0.16 - 0.09 0.04 0.02 - 0.09 0.05 0.06 - 0.05 0.02 0.02 0.02 -0.02 0.06 0.06 -0.04 - 0.05 0.05 0.05 -0.12 0.01 0.01 -0.05 -0.27 -0.03 -0.04 -0.25 -0.6 -0.27 -0.28 -0.33 -0.02 -0.63 -0.05 -0.05 -0.01 -0.02 - - -0.04 - -0.04 -0.03 - -0.05 -0.05 -0.06

ROE %

-2344.68 -117.97 4.80 16.66 19.99 23.60 16.68 14.40 3.90 0.49 -0.89 2.75 -14.50 0.01 14.52 -23.94 -24.15 -25.27 -26.39 90.77 37.81 -0.79 -46.72 -295.33 -333.05 -323.58 -306.92 -1208.32 -1033.58 -1079.97 -1107.26 -73.47 -154.22 73.56 -584.42 -659.25 -633.43 -780.90 -58.49 76.70 114.54 123.82 136.37 137.22 184.77 255.70 458.68 -10385.85 98.41 236.79 -10721.05

ROA %

-11.21 -3.94 1.37 5.17 6.62 7.61 5.12 4.49 1.19 0.25 -0.12 0.87 -3.01 -0.81 1.48 -4.57 -2.26 -1.86 -0.97 10.69 -6.91 -10.97 -15.61 -29.99 -45.08 -49.90 -54.87 -90.53 -156.17 -183.51 -202.96 -183.06 -89.14 -148.50 -176.83 -192.67 -194.79 -123.90 -91.42 -70.54 -82.32 -106.97 -123.61 -123.59 -128.00 -105.07 -86.61 -59.80 -23.79 -19.91 -16.10

ROCE %

-2218.28 -116.05 5.90 18.05 21.20 24.39 16.57 24.42 20.13 16.98 8.06 8.49 -15.29 -1.63 12.04 -23.93 -22.20 -22.16 -22.12 93.32 38.83 6.26 -31.68 -266.33 -302.70 -299.32 -290.70 -1196.04 -1008.48 -1053.88 -1080.59 -56.45 -170.34 87.74 -705.10 -785.80 -744.94 -928.90 -78.21 46.75 89.74 103.06 120.27 142.25 193.23 269.99 486.06 -11300.31 103.44 248.89 -11652.63

Current Ratio

1.0 1.1 1.2 1.4 1.3 1.4 1.4 1.5 1.4 1.4 1.4 1.3 1.4 1.3 1.3 1.3 1.2 1.1 1.2 1.1 1.2 1.1 1.0 1.4 1.1 1.1 1.1 1.5 1.7 1.7 1.0 0.4 2.2 2.5 3.0 1.8 0.6 1.1 1.6 3.5 1.6 2.3 2.9 2.2 1.3 1.8 1.7 - 2.4 2.5 2.8

DSO

65.7 61.6 - 62.5 58.5 62.6 52.6 49.5 2622.7 -3904.4 - 52.9 49.6 44.2 41.5 55.6 46.7 56.0 - 68.6 57.8 56.3 43.6 - 46.0 44.8 - - - - - - - - - - - - - - - - - - 2888.1 - - - - 4154.2 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

71.0 65.9 - 59.5 43.8 35.0 - 51.5 55.5 21.7 - 65.0 53.5 47.0 44.9 65.2 64.8 65.0 58.0 73.5 54.7 56.5 51.5 - 56.4 61.9 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

65.7 61.6 - 62.5 58.5 62.6 52.6 49.5 2622.7 -3904.4 - 52.9 49.6 44.2 41.5 55.6 46.7 56.0 - 68.6 57.8 56.3 43.6 - 46.0 44.8 - - - - - - - - - - - - - - - - - - 2888.1 - - - - 4154.2 -

Cash Conversion Cycle

-5.2 -4.3 - 3.1 14.7 27.7 52.6 -2.0 2567.2 -3926.1 - -12.1 -3.9 -2.8 -3.4 -9.6 -18.1 -9.0 -58.0 -4.8 3.0 -0.2 -7.9 - -10.4 -17.1 - - - - - - - - - - - - - - - - - - 2888.1 - - - - 4154.2 -

All numbers in USD currency